Molecular characterization of circulating tumor cells in patients with ovarian cancer improves their prognostic significance - A study of the OVCAD consortium

Eva Obermayr, Dan Cacsire Castillo-Tong, Dietmar Pils, Paul Speiser, Elena Ioana Braicu, Toon Van Gorp, Sven Mahner, Jalid Sehouli, Ignace Vergote, Robert Zeillinger

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)15-21
JournalGynecologic Oncology
Volume128
Issue number1
DOIs
Publication statusPublished - Jan 2013

Keywords

  • Primary ovarian cancer
  • Circulating tumor cells
  • Molecular marker
  • Platinum resistance
  • Prognostic marker

Cite this

Obermayr, E., Castillo-Tong, D. C., Pils, D., Speiser, P., Braicu, E. I., Van Gorp, T., Mahner, S., Sehouli, J., Vergote, I., & Zeillinger, R. (2013). Molecular characterization of circulating tumor cells in patients with ovarian cancer improves their prognostic significance - A study of the OVCAD consortium. Gynecologic Oncology, 128(1), 15-21. https://doi.org/10.1016/j.ygyno.2012.09.021